Clinical Trial to Assess the Immunogenicity and Safety of the Vero Cell-derived JE Vaccine in Korea

NCT01150942 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

205

Enrollment

INDUSTRY

Sponsor class

Conditions

Japanese Encephalitis

Interventions

BIOLOGICAL: JE vaccine

Sponsor

Boryung Pharmaceutical Co., Ltd

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]